Hrt Financial LP Purple Biotech Ltd. Transaction History
Hrt Financial LP
- $17 Billion
- Q2 2024
A detailed history of Hrt Financial LP transactions in Purple Biotech Ltd. stock. As of the latest transaction made, Hrt Financial LP holds 13,739 shares of PPBT stock, worth $42,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,739Holding current value
$42,041% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PPBT
# of Institutions
17Shares Held
1.67MCall Options Held
5.6KPut Options Held
0-
Armistice Capital, LLC New York, NY1.36MShares$4.16 Million0.01% of portfolio
-
Morgan Stanley New York, NY203KShares$621,1800.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il24.6KShares$75,3610.0% of portfolio
-
Virtu Financial LLC New York, NY19.3KShares$58,9750.0% of portfolio
-
Wealth Advisors Of Iowa, LLC14.3KShares$43,6660.0% of portfolio
About PURPLE BIOTECH LTD.
- Ticker PPBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,303,300
- Market Cap $56M
- Description
- Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...